11.12.2009 • News

Carl Hull Becomes CEO of Gen-Probe

Gen-Probe announced that Carl W. Hull has formally succeeded the company's long-time leader, Henry L. Nordhoff, as CEO. Hull, formerly Gen-Probe's president and COO, also has joined the Company's board of directors. As first announced on March 23, Nordhoff retired as CEO. Nordhoff, who had served as Gen-Probe's CEO since 1994, is now non-executive chairman following his re-election to the board at the Company's annual meeting of stockholders last week.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.